Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
Open Forum Infectious Diseases
|
April 6, 2019
Effectiveness of Direct-Acting Antiviral Therapy in Patients With Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in Routine Clinical Care: A Multicenter Study
H Nina Kim, Robin M Nance, Jessica S Williams-Nguyen, et al.
The Journal of Infectious Diseases
|
November 8, 2025
Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083
Brett Hanscom, Mark A Marzinke, Xinnong Li, et al.
Harm Reduction Journal
|
November 29, 2024
Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities
Angela T Estadt, David Kline, William C Miller, et al.
AIDS Research and Human Retroviruses
|
April 7, 2017
Analysis of HIV Integrase Resistance in Black Men Who Have Sex with Men in the United States
Iris Chen, Yinfeng Zhang, Vanessa Cummings, et al.
American Journal of Epidemiology
|
November 13, 2019
Association Between Chronic Hepatitis C Virus Infection and Myocardial Infarction Among People Living With HIV in the United States
Jessica Williams-Nguyen, Stephen E Hawes, Robin M Nance, et al.
Open Forum Infectious Diseases
|
February 3, 2025
Prevalence and Correlates of Hepatitis C Viremia Among People With Human Immunodeficiency Virus in the Direct-Acting Antiviral Era
Jimmy Ma, Robin M Nance, Edward Cachay, et al.
The Lancet. Infectious Diseases
|
July 8, 2022
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial
Gary A Herman, Meagan P O'Brien, Eduardo Forleo-Neto, et al.
BMC Immunology
|
February 18, 2025
Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people without HIV
Tariro D Chawana, Stephen R Walsh, Lynda Stranix-Chibanda, et al.
The Lancet. HIV
|
December 12, 2024
Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial
Srilatha Edupuganti, Christopher B Hurt, Kathryn E Stephenson, et al.
Ebiomedicine
|
June 14, 2025
Fixed dosing versus weight-based dosing of HIV-1 prophylactic monoclonal antibodies in adults: a post-hoc, cross-protocol pharmacokinetics modelling study
Yunda Huang, Lily Zhang, Huub Gelderblom, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
Open Forum Infectious Diseases
|
April 6, 2019
Effectiveness of Direct-Acting Antiviral Therapy in Patients With Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in Routine Clinical Care: A Multicenter Study
H Nina Kim, Robin M Nance, Jessica S Williams-Nguyen, et al.
The Journal of Infectious Diseases
|
November 8, 2025
Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083
Brett Hanscom, Mark A Marzinke, Xinnong Li, et al.
Harm Reduction Journal
|
November 29, 2024
Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities
Angela T Estadt, David Kline, William C Miller, et al.
AIDS Research and Human Retroviruses
|
April 7, 2017
Analysis of HIV Integrase Resistance in Black Men Who Have Sex with Men in the United States
Iris Chen, Yinfeng Zhang, Vanessa Cummings, et al.
American Journal of Epidemiology
|
November 13, 2019
Association Between Chronic Hepatitis C Virus Infection and Myocardial Infarction Among People Living With HIV in the United States
Jessica Williams-Nguyen, Stephen E Hawes, Robin M Nance, et al.
Open Forum Infectious Diseases
|
February 3, 2025
Prevalence and Correlates of Hepatitis C Viremia Among People With Human Immunodeficiency Virus in the Direct-Acting Antiviral Era
Jimmy Ma, Robin M Nance, Edward Cachay, et al.
The Lancet. Infectious Diseases
|
July 8, 2022
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial
Gary A Herman, Meagan P O'Brien, Eduardo Forleo-Neto, et al.
BMC Immunology
|
February 18, 2025
Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people without HIV
Tariro D Chawana, Stephen R Walsh, Lynda Stranix-Chibanda, et al.
The Lancet. HIV
|
December 12, 2024
Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial
Srilatha Edupuganti, Christopher B Hurt, Kathryn E Stephenson, et al.
Ebiomedicine
|
June 14, 2025
Fixed dosing versus weight-based dosing of HIV-1 prophylactic monoclonal antibodies in adults: a post-hoc, cross-protocol pharmacokinetics modelling study
Yunda Huang, Lily Zhang, Huub Gelderblom, et al.
Page
of 8